Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,964.00
-116.00 (-5.58%)
At close: Mar 11, 2026
Market Cap16.69M -43.5%
Revenue (ttm)34.95M -21.0%
Net Income-40.10M
EPS-47.90
Shares Out849.65K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume812
Average Volume1,899
Open2,027.00
Previous Close2,080.00
Day's Range1,873.00 - 2,027.00
52-Week Range1,703.00 - 4,400.00
Beta0.74
RSI42.70
Earnings DateMar 30, 2026

About TLV:TKUN

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers clinical research, training, and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was founded in 2006 and is based in Nof HaGalil, Israel. [Read more]

Sector Healthcare
Founded 2006
Employees 19
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol TKUN
Full Company Profile

Financial Performance

In 2024, TLV:TKUN's revenue was 34.95 million, a decrease of -20.97% compared to the previous year's 44.23 million. Losses were -40.10 million, -54.88% less than in 2023.

Financial Statements